- Lilly buys another pain biotech; FDA sets decision for once-weekly PrEP pillPlus, news about Merck, MultiValent Biotherapies, Alvotech, enGene, Mirum, and Adaptive Biotechnologies. 💸 Eli Lilly acquires another pain biotech: The Indianapolis pharma giant has made its 11th…Endpoints · 1mo ago↗ source
- STAT+: ARCH-launched Neumora stops depression programA new AI model to improve trial enrollment, importing drugs from Canada, and more biotech news from The ReadoutSTAT · 1mo ago↗ source
- Edgewise heart drug passes key trial testStill, the results leave somewhat unclear how different the company’s drug is than marketed hypertrophic cardiomyopathy medicines from Bristol Myers Squibb and Cytokinetics.BioPharma Dive · 1mo ago